Anti-Tumor Drugs Industry Forecasts - China Focus
- ASI3276372
- 107 Pages
- October 2019
- Pharmaceuticals
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study focuses on industry trends and forecasts with historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.
Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
Market Trends
Technology Development
Market Development
Major Industry Development
Regional Development
Enterprise Development
Labor Market Development
IV. ANTI-TUMOR DRUGS PRODUCTION AND DEMAND
Overview
Anti-Tumor Drugs Production and Demand
Plant Anti-Tumor Drugs
Supply and Demand
Traditional Chinese Anti-Tumor Drugs
Supply and Demand
Anti-Tumor Antibiotics
Supply and Demand
Anti-Metabolite Drugs
Supply and Demand
Platinum Metallic Anti-Tumor Drugs
Supply and Demand
Hormone Anti-Tumor Drugs
Supply and Demand
Aided Anti-Tumor Drugs
Supply and Demand
Immunomodulators
Supply and Demand
Alkylation Anti-Tumor Agents
Supply and Demand
Anti-Tumor Drugs Import and Export
Anti-Tumor Drugs Import
Anti-Tumor Drugs Export
LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
IV. ANTI-TUMOR DRUGS PRODUCTION AND DEMAND
China's Anti-Tumor Drugs Sales Volume and Market Share by Category
China's Major Plant Anti-Tumor Drugs Market Share by Kind
China's Major Traditional Chinese Anti-Tumor Drugs Market Share by Kind
China's Major Antibiotics Drugs Market Share by Kind
China's Major Anti-Metabolite Drugs Market Share by Kind
China's Major Platinum Metallic Anti-Tumor Drugs Market Share by Kind
China's Major Hormone Anti-Tumor Drugs Market Share by Kind
China's Major Aided Anti-Tumor Drugs Market Share by Kind
China's Major Immunomodulators Market Share by Kind
China's Major Alkylation Agents Market Share by Kind
China's Anti-Tumor Drugs Import Volume by Region
China's Anti-Tumor Drugs Export Volume by Region
LIST OF CHARTS
I. INTRODUCTION
China’s Anti-Tumor Drugs Sales Volume
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
IV. ANTI-TUMOR DRUGS PRODUCTION AND DEMAND
China’s Anti-Tumor Drugs Sales Volume
China's Anti-Tumor Drugs Sales Volume and Market Share by Category
China's Plant Anti-Tumor Drugs Sales Volume
China's Major Plant Anti-Tumor Drugs Market Share by Kind
China's Traditional Chinese Anti-Tumor Drugs Sales Volume
China's Major Traditional Chinese Anti-Tumor Drugs Market Share by Kind
China's Anti-Tumor Antibiotics Drugs Sales Volume
China's Major Anti-Tumor Antibiotics Drugs Market Share by Kind
China's Anti-Metabolite Drugs Sales Volume
China's Major Anti-Metabolite Drugs Market Share by Kind
China's Platinum Metallic Anti-Tumor Drugs Sales Volume
China's Major Platinum Metallic Anti-Tumor Drugs Market Share by Kind
China's Hormone Anti-Tumor Drugs Sales Volume
China's Major Hormone Anti-Tumor Drugs Market Share by Kind
China's Aided Anti-Tumor Drugs Sales Volume
China's Major Aided Anti-Tumor Drugs Market Share by Kind
China's Immunomodulators Sales Volume
China's Major Immunomodulators Market Share by Kind
China's Alkylation Anti-Tumor Agents Sales Volume
China's Major Alkylation Anti-Tumor Agents Market Share by Kind
China’s Anti-Tumor Drugs Import Volume
China's Anti-Tumor Drugs Import Volume by Region
China’s Anti-Tumor Drugs Export Volume
China’s Anti-Tumor Drugs Import and Export
China's Anti-Tumor Drugs Export Volume by Region
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
